Physiological Role
Gamma-glutamyltransferase is a membrane-bound enzyme present on the surface of cells in several organs, primarily the liver, kidneys and pancreas. Its central role involves cleaving the gamma-glutamyl bond of extracellular glutathione, the body’s primary antioxidant system. This cleavage releases glutathione’s constituent amino acids (cysteine, glutamate, glycine), enabling their reabsorption and intracellular glutathione resynthesis.
Unlike ALT, an intracellular enzyme released upon hepatocyte damage, GGT is anchored in the cell membrane. It actively participates in the glutathione cycle, called the gamma-glutamyl cycle. This membrane position explains its sensitivity to numerous metabolic, toxic and inflammatory factors. Any hepatic stress, even moderate, stimulates GGT synthesis.
In blood, circulating GGT primarily originates from the liver, although the enzyme is expressed in other tissues. This is why a serum elevation is interpreted as a hepatic signal, even though extra-hepatic factors can also influence it.
Reference Ranges
These reference ranges are derived from scientific literature and may differ from your laboratory's reference values.
Source : MedlinePlus, Gamma-glutamyl transferase test (2024)
Biological Significance
A GGT level in the optimal range reflects a functional liver and a preserved balance between oxidative burden and antioxidant capacity. This scenario is associated with a favorable metabolic profile in long-term follow-up studies.
Elevated values constitute a metabolic warning signal. GGT is the most reactive hepatic marker to alcohol consumption. Its elevation can also reflect fatty liver, metabolic syndrome or cholestasis (slowed bile flow). Recent research shows that elevated GGT, even in isolation, is an independent predictor of cardiovascular risk.
Very low values are generally reassuring and reflect low hepatic stress. Unlike ALT, a very low GGT level is not associated with specific risks in current literature.
GGT reading gains full meaning when combined with ALT. An isolated GGT elevation points toward a biliary or toxic cause. A joint elevation of both markers suggests more global hepatocellular stress. The trend of values over time is more informative than a single measurement.
Influencing Factors
Alcohol. GGT is the most sensitive biological marker to alcohol consumption. Even regular moderate intake can elevate values. After cessation, GGT typically returns to baseline within two to five weeks.
Medications. Antiepileptics (phenytoin, carbamazepine), certain antibiotics and non-steroidal anti-inflammatory drugs can induce GGT elevation. Oral contraceptives and hormone replacement therapies also influence levels.
Body composition. Obesity and visceral adiposity are factors of chronic GGT elevation. Metabolic syndrome is strongly correlated with elevated values, independently of alcohol consumption.
Diet. A caloric excess rich in saturated fats and refined sugars promotes fat accumulation in the liver and GGT elevation. Conversely, a diet rich in fruits, vegetables and coffee is associated with lower values in epidemiological studies.
Age and sex. Men present higher GGT values than women. Levels increase with age in both sexes, making longitudinal monitoring particularly relevant.
Tobacco. Smoking is an independent factor of GGT elevation, likely related to increased oxidative burden on the liver.
Physical activity. Regular physical activity is associated with lower GGT values. This effect is particularly marked in overweight individuals or those with metabolic syndrome.
In the Singular Formula
GGT is among the hepatic markers integrated into the Singular formulation engine. Its direct link to glutathione metabolism makes it a key indicator for calibrating the formula’s antioxidant support.
When GGT falls in the high or very high range, the formulation engine activates a hepatic support protocol. N-acetylcysteine dosage is increased to support glutathione synthesis, the antioxidant system that GGT helps recycle. Reishi, a functional mushroom whose triterpenes are documented for their hepatic tissue affinity, also sees its dosage increased.
Beyond the ruleset, the Singular formula includes other bioactives whose influence on hepatic function is documented in the literature. Sulforaphane, an isothiocyanate derived from broccoli, is studied for its role in hepatic detoxification pathways. Curcumin is the subject of research evaluating its influence on liver enzymes, including GGT.
This hepatic support rule is shared with ALT, the other liver marker measured by Singular. The combination of both markers allows the formulation engine to distinguish isolated hepatic stress from a metabolic profile requiring a coordinated response.
Linked Bioactives
Scientific Studies
| Authors | Year | Type | Journal | |
|---|---|---|---|---|
| Ruttmann E. et al. | 2005 | Cohort Study | Circulation | View on PubMed |
Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults In this Austrian cohort of 163,944 adults followed over 17 years, elevated GGT is significantly associated with cardiovascular mortality in both men and women, with a dose-response relationship. | ||||
| Fraser A. et al. | 2007 | Meta-analysis | Arteriosclerosis, Thrombosis, and Vascular Biology | View on PubMed |
Gamma-glutamyltransferase is associated with incident vascular events independently of alcohol intake: analysis of the British Women's Heart and Health Study and Meta-Analysis This meta-analysis combined with a cohort study demonstrates that GGT is associated with vascular events independently of alcohol intake, supporting its role as a broad metabolic marker. | ||||
| Du G. et al. | 2013 | Meta-analysis | Preventive Medicine | View on PubMed |
Gamma-glutamyltransferase is associated with cardiovascular and all-cause mortality: a meta-analysis of prospective cohort studies Meta-analysis of seven prospective studies involving 273,141 participants. Elevated GGT is an independent predictor of cardiovascular and all-cause mortality. | ||||
| Kunutsor S.K. et al. | 2014 | Meta-analysis | International Journal of Epidemiology | View on PubMed |
Liver enzymes and risk of all-cause mortality in general populations: a systematic review and meta-analysis Systematic review evaluating the link between liver enzymes (GGT, ALT, AST) and all-cause mortality in general populations. GGT shows the most robust association with mortality risk. | ||||
| Koenig G. et Seneff S. | 2015 | Systematic Review | Disease Markers | View on PubMed |
Gamma-Glutamyltransferase: A Predictive Biomarker of Cellular Antioxidant Inadequacy and Disease Risk Review detailing GGT’s role as an indicator of cellular antioxidant status. Elevated GGT reflects increased glutathione demand, signaling systemic oxidative stress. | ||||
| Whitfield J.B. | 2001 | Systematic Review | Critical Reviews in Clinical Laboratory Sciences | View on PubMed |
Gamma glutamyl transferase Reference review on GGT biochemistry, physiology and clinical significance. Describes enzymatic regulation mechanisms and causes of serum elevation. | ||||
| Lee D.H. et al. | 2004 | Systematic Review | Free Radical Research | View on PubMed |
Is serum gamma glutamyltransferase a marker of oxidative stress? Study exploring the relationship between serum GGT and oxidative stress markers. The authors propose GGT as an indirect indicator of systemic oxidative stress. | ||||